ISSCR 2016

5 big picture stem cell trends at #ISSCR2016

ISSCR-2016-packed-house-e1466961505769

Now that the ISSCR annual meeting is over, some overall stem cell trends are evident from the meeting in terms of the direction of the stem cell field. This was one of my favorite ISSCR meetings. Translation expectation and upbeat tone. The overall vibe at the meeting was a sense of excitement and optimism about the …

5 big picture stem cell trends at #ISSCR2016 Read More »

Shinya Yamanaka at #ISSCR2016 on reprogramming of cells & scientists

ISSCR-2016-packed-house-e1466961505769

The second day of ISSCR 2016 started off with a great session on pluripotency and plasticity, and the first talk was by Shinya Yamanaka. He changed the title of his talk to “Reprogramming of Cells and Scientist”. As with my other posts on this meeting, this one is a stream of quotes and impressions from …

Shinya Yamanaka at #ISSCR2016 on reprogramming of cells & scientists Read More »

Austin Smith talk at #ISSCR2016: a ground state inhibitor pathway

ISSCR-2016-packed-house-e1466961505769

ISSCR 2016’s first plenary session is focused on stem cells & cancer. I was really excited about this one even before the meeting as this topic is a major focus of my own lab. Here’s the lineup for this plenary with great expertise in stem cells & cancer from across the globe: President’s Address: Sean Morrison, Children’s …

Austin Smith talk at #ISSCR2016: a ground state inhibitor pathway Read More »

Stem cell news bites: Mesoblast, BioTime, MS, FDA Warning, & More

Mesoblast-stock

Stem cell studies continue to make big news with a mixed bag of trends, and some good stem cell news and others not so much. Mesoblast ($MESO) had its stock suspended for quite so time recently in anticipation of a big announcement. When that news came today it was discouraging in the form of its partner …

Stem cell news bites: Mesoblast, BioTime, MS, FDA Warning, & More Read More »